Laddar...

Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome

The goal of this study was to assess the clinical performance of an investigational in vitro fecal calprotectin immunoassay for differentiating inflammatory bowel disease (IBD) from irritable bowel syndrome (IBS). BACKGROUND: Fecal calprotectin is a stool biomarker that can assist in the detection o...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Clin Gastroenterol
Huvudupphovsmän: Campbell, James P., Zierold, Claudia, Rode, Ashli M., Blocki, Frank A., Vaughn, Byron P.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Lippincott Williams & Wilkins 2021
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7960147/
https://ncbi.nlm.nih.gov/pubmed/32324678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCG.0000000000001359
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!